Paul R Cooper
Paul undertook a BSc degree in Genetics at Leeds University which he completed in 1992. He then undertook a PhD in Cancer Studies at the University of Birmingham, conducting research into cloning of the gene for Ataxia Telangiectasia, which he completed in 1995. He subsequently undertook a postdoctoral position at Roswell Park Cancer Institute, Buffalo, New York for two years working on the molecular genetics of eye, ear and cancer predisposing disorders and contributed to the cloning of the NBS1 gene (encoding Nibrin) which is mutated in patients with Nijmegen-breakage syndrome.
He returned to the UK in 1998 as a postdoctoral researcher at the Novartis Horsham Research Centre. He worked there 2 years on the identification of molecular targets in granulocytes and epithelium in inflammatory lung diseases such as asthma and COPD. Paul returned to Birmingham in 2000 where he was appointed Lecturer in Molecular Biology and he initiated a programme of research on tissue regeneration and repair and inflammatory/immune aspects of oral and dental diseases. He was promoted to Senior Lecturer in Molecular Biology in 2006 and appointed to Professor of Oral Biology in August 2012.
In 2010, he received the prestigious Young Investigator Award from the International Association for Dental Research. He has many research collaborations around the world and frequently speaks at symposia worldwide.